Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK559659PMID: 32697464
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 171596-29-5
Drug Levels and Effects
Summary of Use during Lactation
No published information is available on the use of tadalafil during breastfeeding. An alternate agent may be preferred.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Tadalafil
CAS Registry Number
171596-29-5
Drug Class
Breast Feeding
Lactation
Phosphodiesterase 5 Inhibitors
Urologic Agents
Vasodilator Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.[Eur Urol. 2004]Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V. Eur Urol. 2004 Sep; 46(3):362-9; discussion 369.
- Identification of a new tadalafil analogue, N-3-hydroxypropylnortadalafil, in a supplement product.[J Pharm Biomed Anal. 2018]Identification of a new tadalafil analogue, N-3-hydroxypropylnortadalafil, in a supplement product.Lee HC, Lin YL, Huang YC, Tsai CF, Wang DY. J Pharm Biomed Anal. 2018 Sep 5; 158:257-261. Epub 2018 Jun 1.
- Comparison between counterfeit and authentic medicines: A novel approach using differential scanning calorimetry and hierarchical cluster analysis.[J Pharm Biomed Anal. 2019]Comparison between counterfeit and authentic medicines: A novel approach using differential scanning calorimetry and hierarchical cluster analysis.Dos Santos MK, de Cassia Mariotti K, Kahmann A, Anzanello MJ, Ferrão MF, de Araújo Gomes A, Limberger RP, Ortiz RS. J Pharm Biomed Anal. 2019 Mar 20; 166:304-309. Epub 2019 Jan 17.
- Review Cialis (tadalafil): a new treatment for erectile dysfunction.[Hosp Med. 2003]Review Cialis (tadalafil): a new treatment for erectile dysfunction.Minhas S, Kalsi JS, Ralph DJ. Hosp Med. 2003 Oct; 64(10):589-92.
- Review Lefamulin.[Drugs and Lactation Database (...]Review Lefamulin.. Drugs and Lactation Database (LactMed®). 2006
- Tadalafil - Drugs and Lactation Database (LactMed®)Tadalafil - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...